Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor today announced the election of David R. Myers, VP of National Accounts, to the Bellwether League Foundation's Hall of Fame.

David R. Myers of Owens & Minor Receives Prestigious Bellwether League Foundation Hall of Fame Recognition

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Owens & Minor (OMI) Q2 Earnings Expected to Decline

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Announces Second Quarter 2022 Earnings Release Date

Owens & Minor Announces Second Quarter 2022 Earnings Release Date

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a leading global healthcare solutions company, today announced that Carissa Rollins, Chief Information Officer (CIO) at Illumina, Inc., has been elected to its Board of Directors, effective July 12, 2022. “Carissa's experience driving strategy for global information systems and information technology for industry-leading healthcare companies brings a unique new perspective to the Board,” said Mark A. Beck, Chair of the Board,

Owens & Minor Elects Carissa Rollins to Board of Directors

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor won its seventh Supplier Legacy Award for its consistent, long-time support of Premier's hospital, health system and provider members.

Owens & Minor Wins Seventh Premier GPO Supplier Legacy Award

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor today broke ground on a state-of-the-art hub for managing and coordinating complex medical supply logistics in West Virginia and beyond.

Owens & Minor Breaks Ground on Center of Excellence for Medical Supply Logistics in West Virginia

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor names Tammy Gomez EVP & Chief Human Resources Officer, effective July 11. Gomez will assume leadership of the company's people strategy.

Owens & Minor Names Tammy Gomez EVP and Chief Human Resources Officer

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor today announced that Rita Johnson-Mills and Terri Kline have been elected to its Board of Directors, effective June 1, 2022.

Owens & Minor Elects Rita Johnson-Mills and Terri Kline to Board of Directors

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor to Participate in the UBS Global Healthcare Conference 2022 on Monday, May 23, 2022

Owens & Minor to Participate in the UBS Global Healthcare Conference 2022 Monday, May 23, 2022

Group 1 Automotive

Helmerich & Payne

PBF Energy

Allegiant Travel Company

Independent Bank Group

Select Medical Holdings

Times are tough for small-cap stocks, but you can still find some great stocks to buy in funds focused on these smaller companies. The post 3 Stocks to Buy (And 4 to Skip) in This Small-Cap Value ETF appeared first on InvestorPlace.

3 Stocks to Buy (And 4 to Skip) in This Small-Cap Value ETF

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that Ed Pesicka, President & Chief Executive Officer, and Andy Long, Executive Vice President & Chief Financial Officer, will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10th at 10:00 AM PT. A live webcast and replay may be accessed at www.owens-minor.com under the investor relations section at investors.owens-minor.com/events-presentations/. Please vi

Owens & Minor to Participate in the BofA Securities 2022 Healthcare Conference Tuesday, May 10, 2022

Owens & Minor, Inc. (NYSE:OMI ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Edward A. Pesicka – President and Chief Executive Officer Andrew G.

Owens & Minor, Inc. (OMI) CEO Edward A. Pesicka on Q1 2022 Results - Earnings Call Transcript

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Reports First Quarter 2022 Financial Results

Owens & Minor Reports First Quarter 2022 Financial Results

Earnings Preview: Owens & Minor (OMI) Q1 Earnings Expected to Decline

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2022 after market close on Tuesday, May 3, 2022. The Company will host a conference call for investors at 4:30 p.m. ET to review its financial results. Participants may access the call at 866-393-1604. The international dial-in number is 1-224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call,

Owens & Minor will Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022

Here is how Owens & Minor (OMI) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.

Has Owens & Minor (OMI) Outpaced Other Medical Stocks This Year?

Owens & Minor (OMI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Here's Why Owens & Minor (OMI) Looks Ripe for Bottom Fishing

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor announced that it has completed the acquisition of Apria, expanding the company's presence in the growing home healthcare market

Owens & Minor, Inc. Completes Acquisition of Apria, Inc.

Is Owens & Minor (OMI) a great pick from the value investor's perspective right now? Read on to know more.

Is Owens & Minor (OMI) a Great Stock for Value Investors?

Medtronic

Thermo Fisher Scientific

MedTech stocks like Owens & Minor (OMI), Thermo Fisher (TMO) and Medtronic (MDT) are prudent investment choices given their long-term growth potential with recent M&A deals.

3 Stocks to Focus on With MedTech M&A Scaling New Heights

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today the upsize and pricing of its private offering (the “Offering”) of $600 million aggregate principal amount of its 6.625% senior notes due 2030 (the “Notes”), representing an increase of $100 million aggregate principal amount from the previously announced offering size. The Offering is expected to close on March 29, 2022, subject to customary closing conditions. The Notes will bear interest at the

Owens & Minor Announces Upsize and Pricing of $600 Million of Senior Notes Due 2030

We think that Intuit stock, a company that specializes in financial and tax preparation software, currently is a better pick compared to medical devices maker Owens & Minor stock, a global healthcare logistics company, despite INTU being more expensive of the two with its P/S ratio of 11.0x.

Is There A Better Pick Over Owens & Minor Stock?

Healthcare technology company Owens & Minor Inc. OMI, +3.25% said Friday it has launched a private offering of $500 million of 8-year high-yield bonds. Proceeds will be used to fund the acquisition of Apria Inc. with any remaining money to be used for general corporate purposes.

Owens & Minor launches private offering of $500 million of 8-year high-yield bonds to fund Apria acquisition

RICHMOND, Va.--(BUSINESS WIRE)--OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING

Owens & Minor Announces Launch of Senior Notes Offering

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor essential medical supplies donation to Ukraine

News for Owens & Minor Stock (OMI)